https://www.selleckchem.com/products/mtx-211.html
08; 95% CI 1.13, 3.83), activated partial thromboplastin time ≥37 s (OR 3.07; 95% CI 1.37, 6.86), D-dimer ≥ 0.5 mg/L (OR 2.12; 95% CI 1.33, 3.36) and procalcitonin ≥0.5 μg/L (OR 3.58; 95% CI 1.40, 9.14). The area under curve of ROC curve was 0.773 (95% CI 0.723, 0.822; p .01). The risk score had robustness and generalizability after validation. Cardiovascular complications were significantly associated with poorer survivals (log-rank test p .001). We developed and validated a novel risk score, which has a promising predictive
Like
Comment
Share
